Core Laboratories
CLB
178 hedge funds and large institutions have $1.16B invested in Core Laboratories in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 56 increasing their positions, 66 reducing their positions, and 8 closing their positions.
296% more call options, than puts
Call options by funds: $1.01M | Put options by funds: $255K
175% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 8
9% more funds holding
Funds holding: 164 → 178 (+14)
2% more capital invested
Capital invested by funds: $1.13B → $1.16B (+$26.3M)
0.88% less ownership
Funds ownership: 104.51% → 103.64% (-0.88%)
15% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 66
Top Buyers
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$10.7M |
| 2 |
Fisher Asset Management
Camas,
Washington
|
+$10.6M |
| 3 |
State Street
Boston,
Massachusetts
|
+$5.63M |
| 4 |
Morgan Stanley
New York
|
+$3.93M |
| 5 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
+$3.79M |
Top Sellers
| 1 |
FAM
Fred Alger Management
New York
|
-$34.4M |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
-$13.9M |
| 3 |
BlackRock
New York
|
-$4.15M |
| 4 |
SC
Sagefield Capital
Dallas,
Texas
|
-$3.79M |
| 5 |
AP
Advisors Preferred
Rockville,
Maryland
|
-$2.5M |
CLB Hedge Fund Activity: Q3 2023 in Review
178 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q3 2023, worth a combined $1.16B — up 2.3% from $1.13B a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new CLB positions and 8 closed out — a net gain of 14 holders — while 56 added to existing stakes and 66 trimmed.
The largest buyer was LMR Partners, opening a new position worth an estimated $10.7M. The largest seller was Fred Alger Management, cutting an estimated $34.4M.
- 178 institutional investors held Core Laboratories (CLB) as of Q3 2023, up from 164 in Q2 2023.
- Funds reported $1.16B of Core Laboratories stock for Q3 2023, up 2.3% quarter-over-quarter.
- 22 funds opened new Core Laboratories positions in Q3 2023 and 8 closed out, a net change of +14 holders.
- The largest Core Laboratories buyer in Q3 2023 was LMR Partners, an estimated $10.7M added.
- The largest Core Laboratories seller in Q3 2023 was Fred Alger Management, an estimated $34.4M sold.
Based on aggregated 13F filings for Q3 2023.